STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress

We provide unprecedented genetic and biochemical evidence that the antiapoptotic transcription factor STAT3 serves as a substrate for SYK tyrosine kinase both in vitro and in vivo. Induction of SYK in an ecdysone-inducible mammalian expression system results in STAT3 activation, as documented by tyrosine phosphorylation and nuclear translocation of STAT3, as well as amplified expression of several STAT3 target genes. STAT3 activation after oxidative stress (OS) is strongly diminished in DT40 chicken B-lineage lymphoma cells rendered SYK-deficient by targeted disruption of the syk gene. Introduction of a wild-type, C-terminal or N-terminal SH2 domain-mutated, but not a kinase domain-mutated, syk gene into SYK-deficient DT40 cells restores OS-induced enhancement of STAT-3 activity. Thus, SYK plays an important and indispensable role in OS-induced STAT3 activation and its catalytic SH1 domain is critical for this previously unknown regulatory function. These results provide evidence for the existence of a novel mode of cytokine-independent cross-talk that operates between SYK and STAT3 pathways and regulates apoptosis during OS. We further provide experimental evidence that SYK is capable of associating with and phosphorylating STAT3 in human B-lineage leukemia/lymphoma cells challenged with OS. In agreement with a prerequisite role of SYK in OS-induced STAT3 activation, OS does not induce tyrosine phosphorylation of STAT3 in SYK-deficient human proB leukemia cells. Notably, inhibition of SYK with a small molecule drug candidate prevents OS-induced activation of STAT3 and overcomes the resistance of human B-lineage leukemia/lymphoma cells to OS-induced apoptosis.

[1]  Xiao Jun,et al.  Specificity of α-Cyano-β-Hydroxy-β-Methyl-N-[4-(Trifluoromethoxy)Phenyl]-Propenamide as an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase , 1999 .

[2]  B cells. , 2005, Critical care medicine.

[3]  Y. Tohyama,et al.  Lysosome is a primary organelle in B cell receptor‐mediated apoptosis: an indispensable role of Syk in lysosomal function , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[4]  F. Uckun,et al.  COBRA-1, a rationally-designed epoxy-THF containing compound with potent tubulin depolymerizing activity as a novel anticancer agent. , 2000, Bioorganic & medicinal chemistry letters.

[5]  Specificity of a-Cyano-b-Hydroxy-b-Methyl-N- [4-(Trifluoromethoxy)Phenyl]-Propenamide as an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase , 1999 .

[6]  X. P. Liu,et al.  Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  Francesco Bertoni,et al.  Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma , 2006, British journal of haematology.

[8]  Jens Timmer,et al.  Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. , 2009, Cancer research.

[9]  S. Kuo,et al.  Antitumor agents. Part 204: synthesis and biological evaluation of substituted 2-aryl quinazolinones. , 2001, Bioorganic & medicinal chemistry letters.

[10]  S. Corey,et al.  Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway , 2007, Oncogene.

[11]  T. Kurosaki,et al.  BTK as a Mediator of Radiation-Induced Apoptosis in DT-40 Lymphoma B Cells , 1996, Science.

[12]  Y. Refaeli,et al.  Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target. , 2009, Blood.

[13]  K. Alitalo,et al.  The Bmx tyrosine kinase induces activation of the Stat signaling pathway, which is specifically inhibited by protein kinase Cdelta. , 1997, Blood.

[14]  M. David,et al.  Rapid STAT Phosphorylation via the B Cell Receptor , 1999, The Journal of Biological Chemistry.

[15]  S. Rudikoff,et al.  IL-6 mediated activation of STAT3 bypasses Janus kinases in terminally differentiated B lineage cells , 2002, Oncogene.

[16]  H. Shih,et al.  Kinase Activation of the Non-receptor Tyrosine Kinase Etk/BMX Alone Is Sufficient to Transactivate STAT-mediated Gene Expression in Salivary and Lung Epithelial Cells* , 1999, Journal of Biological Chemistry.

[17]  R. Jove,et al.  The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activity. , 1999, Cellular signalling.

[18]  T. Stankovic,et al.  Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling. , 2004, Blood.

[19]  S. Armstrong,et al.  Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia. , 2005, Cancer research.

[20]  Ying-Xuan Chen,et al.  Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. , 2008, Neoplasia.

[21]  B. Stillman,et al.  Simian virus 40 large T antigen binds to topoisomerase I. , 1996, Virology.

[22]  T. Kurosaki,et al.  A deficiency in Syk enhances ceramide‐induced apoptosis in DT40 lymphoma B cells , 1998, FEBS letters.

[23]  Cheng Cheng,et al.  Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. , 2004, The New England journal of medicine.

[24]  N. Reich,et al.  Identification of STAT3 as a specific substrate of breast tumor kinase , 2006, Oncogene.

[25]  S. Armstrong,et al.  Gene Expression Profiling Identifies BAX-δ as a Novel Tumor Antigen in Acute Lymphoblastic Leukemia , 2005 .

[26]  K. Sada,et al.  Structure and function of Syk protein-tyrosine kinase. , 2001, Journal of biochemistry.

[27]  F. Uckun,et al.  Bruton's tyrosine kinase prevents activation of the anti‐apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B‐cells and B‐cell precursors exposed to oxidative stress , 2007, British journal of haematology.

[28]  Herbert Schulz,et al.  Novel STAT3 Target Genes Exert Distinct Roles in the Inhibition of Mesoderm and Endoderm Differentiation in Cooperation with Nanog , 2009, Stem cells.

[29]  Y. Tohyama,et al.  B cell responses to oxidative stress. , 2004, Current pharmaceutical design.

[30]  M. Farrar,et al.  BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. , 2009, Blood.

[31]  A. Burkhardt,et al.  Physical and Functional Interactions between Lyn and p34 Kinases in Irradiated Human B-cell Precursors (*) , 1996, The Journal of Biological Chemistry.

[32]  Jinsong He,et al.  Role of BLNK in oxidative stress signaling in B cells. , 2001, Antioxidants & redox signaling.

[33]  R. Jove,et al.  Activation of STAT3 by the c-Fes Protein-tyrosine Kinase* , 1998, The Journal of Biological Chemistry.

[34]  K. Sameith,et al.  Stratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical response. , 2009, Blood.

[35]  M. Schrappe,et al.  Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia , 2003, Nature.

[36]  B. Lange,et al.  Bone-marrow relapse in paediatric acute lymphoblastic leukaemia. , 2008, The Lancet. Oncology.

[37]  S. Hubbard.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog , 1997, The EMBO journal.

[38]  T. Rothstein,et al.  Lymphokine dependence of STAT3 activation produced by surface immunoglobulin cross‐linking and by phorbol ester plus calcium ionophore treatment in B cells , 2001, European journal of immunology.

[39]  S. Akira,et al.  Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. , 2003, The Journal of clinical investigation.

[40]  R. Evans,et al.  Ecdysone-inducible gene expression in mammalian cells and transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. den Hertog,et al.  H2O2-induced Intermolecular Disulfide Bond Formation between Receptor Protein-tyrosine Phosphatases* , 2004, Journal of Biological Chemistry.

[42]  D. Taub,et al.  Tyrphostin AG‐490 inhibits cytokine‐mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen‐activated human T cells , 1999, Journal of leukocyte biology.

[43]  Simon C Watkins,et al.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Fatih M. Uckun,et al.  Transcription Factor STAT5A Is a Substrate of Bruton's Tyrosine Kinase in B Cells* , 2001, The Journal of Biological Chemistry.

[45]  J. Cherrington,et al.  Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells. , 2003, Molecular cancer therapeutics.

[46]  F. Uckun,et al.  Calpain inhibitor II induces caspase-dependent apoptosis in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells as well as some solid tumor cells. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  F. Uckun,et al.  Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton′s Tyrosine Kinase (BTK), LFM-A13 [α-Cyano-β-Hydroxy-β-Methyl-N-(2,5-Dibromophenyl)Propenamide]* , 1999, The Journal of Biological Chemistry.

[48]  C. Song,et al.  Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia. , 1993, The Journal of clinical investigation.

[49]  V. Poli,et al.  Cutting Edge: Inherent and Acquired Resistance to Radiation-Induced Apoptosis in B Cells: A Pivotal Role for STAT31 , 2006, The Journal of Immunology.

[50]  B. Zhong,et al.  Regulation of Akt-dependent cell survival by Syk and Rac. , 2003, Blood.

[51]  G. Leone,et al.  Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells , 2009, Leukemia.

[52]  S. Enosawa,et al.  Stat3 confers resistance against hypoxia/reoxygenation-induced oxidative injury in hepatocytes through upregulation of Mn-SOD. , 2004, Journal of hepatology.

[53]  F. Uckun,et al.  2,4,6-Trihydroxy-&agr;-p-methoxyphenylacetophenone (Compound D-58) Is a Potent Inhibitor of Allergic Reactions , 2001, American journal of therapeutics.

[54]  G. Schieven,et al.  Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase- dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes , 1993 .

[55]  F. Uckun,et al.  Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia , 2001, Oncogene.

[56]  A. Borkhardt,et al.  Deregulated Syk inhibits differentiation and induces growth factor–independent proliferation of pre–B cells , 2006, The Journal of experimental medicine.

[57]  Stefano Monti,et al.  SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. , 2008, Blood.

[58]  David Steele,et al.  Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  A. Burkhardt,et al.  Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. , 1993, The Journal of biological chemistry.

[60]  J. Harbott,et al.  Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. , 2004, Blood.

[61]  S. Akira,et al.  Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. , 1998, Journal of immunology.

[62]  T. Takano,et al.  Syk Is Required for the Activation of Akt Survival Pathway in B Cells Exposed to Oxidative Stress* , 2000, The Journal of Biological Chemistry.